Variant B.1.617.1 (Kappa ) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)
Sipariş numarası: P4016.0025
Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!Teslim süresi 30 İş günü
Fiyatlar artı KDV artı nakliye maliyetleri
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020. Data from the RKI (Germany): India, Oct. 2020: G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H.
Peptide sequences included (each with 25µg):
KVCEFQFCNDPFLDV NGVQGFNCYFPLQSY PAHEKNFTTAPAICH FQFCNDPFLDVYYHK GTNTSNQVAVLYQGV NDPFLDVYYHKNNKS SNQVAVLYQGVNCTE LDVYYHKNNKSWMKS AVLYQGVNCTEVPVA YHKNNKSWMKSEFRV QGVNCTEVPVAIHAD NKSWMKSEFRVYSSA GICASYQTQTNSRRR MKSEFRVYSSANNCT SYQTQTNSRRRARSV LDSKVGGNYNYRYRL QTNSRRRARSVASQS VGGNYNYRYRLFRKS RRRARSVASQSIIAY YNYRYRLFRKSNLKP PHGVVFLHVTYVPAH YQAGSTPCNGVQGFN VFLHVTYVPAHEKNF STPCNGVQGFNCYFP VTYVPAHEKNFTTAP
Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
Protein ID: P0DTC2 (swiss prot)
Technische Daten:
Specifications:
Pool of 25 peptides of mutant B.1.617.1 (Kappa).
India, Oct. 2020 G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H
Quantity: approx. 25µg per peptide (0.625mg in total)
Peptides supplied as trifluoro acetate salts
Quality check: by ESI-MS
Protein ID: P0DTC2 (swiss prot)
Applikation:
T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.Sicherheits Hinweise / Safety
Klassifizierungen / Classification
eclass-Nr: 32-16-04-09Dokumente - Protokolle - Downloads
Hier finden Sie Informationen und weiterführende Literatur zu Variant B.1.617.1 (Kappa ) Peptide Pool SARS-CoV-2 (Spike Glycoprotein). Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.